SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-099181
Filing Date
2023-04-12
Accepted
2023-04-12 16:05:58
Documents
14
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d425141ddef14a.htm DEF 14A 568742
2 GRAPHIC g425141g01a01.jpg GRAPHIC 37467
3 GRAPHIC g425141g06a06.jpg GRAPHIC 55920
4 GRAPHIC g425141g11f13.jpg GRAPHIC 1306
5 GRAPHIC g425141g13j07.jpg GRAPHIC 17377
6 GRAPHIC g425141g51w01.jpg GRAPHIC 53138
7 GRAPHIC g425141g73l41.jpg GRAPHIC 60831
8 GRAPHIC g425141g90t91.jpg GRAPHIC 23079
9 GRAPHIC g425141snap10.jpg GRAPHIC 949
10 GRAPHIC g425141snap12.jpg GRAPHIC 1126
11 GRAPHIC g425141snap13.jpg GRAPHIC 1038
12 GRAPHIC g425141snap9.jpg GRAPHIC 1041
13 GRAPHIC g425141sp1.jpg GRAPHIC 4129
14 GRAPHIC g425141sp2new.jpg GRAPHIC 1338
  Complete submission text file 0001193125-23-099181.txt   928119
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39659 | Film No.: 23815725
SIC: 8071 Services-Medical Laboratories